The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anti-tumor Injection Market Research Report 2024
Synopsis
Anti-tumor injections are a class of drugs specifically used to treat tumors. They can inhibit the growth and spread of tumor cells through different mechanisms.
The global Anti-tumor Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Anti-tumor Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Anti-tumor Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Anti-tumor Injection include Roche(Genentech), Bayer, Novartis, Pfizer, Amgen, Mabxience, Luoxin Pharmaceutical, Qilu Pharmaceutical and Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Anti-tumor Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-tumor Injection.
Report Scope
The Anti-tumor Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-tumor Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-tumor Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche(Genentech)
Bayer
Novartis
Pfizer
Amgen
Mabxience
Luoxin Pharmaceutical
Qilu Pharmaceutical
Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.)
Fuxing Medicine
Yuekang Pharmaceutical
Yuheng Pharmaceutical
Hengrui Medicine
Huiyu Pharmaceutical
Changbaishan Pharmaceutical Co., Ltd.
Innovent Biologics (Suzhou) Co., Ltd.
Yifan Pharmaceutical
Segment by Type
Paclitaxel Injection
Cisplatin Injection
Cyclophosphamide Injection
Vincristine Injection
Others
Segment by Application
Breast Cancer
Stomach Cancer
Ovarian Cancer
Lung Cancer
Cervical Cancer
Endometrial Cancer
Prostate Cancer
Bladder Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-tumor Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-tumor Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Anti-tumor injections are a class of drugs specifically used to treat tumors. They can inhibit the growth and spread of tumor cells through different mechanisms.
The global Anti-tumor Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Anti-tumor Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Anti-tumor Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Anti-tumor Injection include Roche(Genentech), Bayer, Novartis, Pfizer, Amgen, Mabxience, Luoxin Pharmaceutical, Qilu Pharmaceutical and Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Anti-tumor Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-tumor Injection.
Report Scope
The Anti-tumor Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-tumor Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-tumor Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche(Genentech)
Bayer
Novartis
Pfizer
Amgen
Mabxience
Luoxin Pharmaceutical
Qilu Pharmaceutical
Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.)
Fuxing Medicine
Yuekang Pharmaceutical
Yuheng Pharmaceutical
Hengrui Medicine
Huiyu Pharmaceutical
Changbaishan Pharmaceutical Co., Ltd.
Innovent Biologics (Suzhou) Co., Ltd.
Yifan Pharmaceutical
Segment by Type
Paclitaxel Injection
Cisplatin Injection
Cyclophosphamide Injection
Vincristine Injection
Others
Segment by Application
Breast Cancer
Stomach Cancer
Ovarian Cancer
Lung Cancer
Cervical Cancer
Endometrial Cancer
Prostate Cancer
Bladder Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-tumor Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-tumor Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Anti-tumor Injection Market Overview
1.1 Product Overview and Scope of Anti-tumor Injection
1.2 Anti-tumor Injection Segment by Type
1.2.1 Global Anti-tumor Injection Market Value Comparison by Type (2024-2030)
1.2.2 Paclitaxel Injection
1.2.3 Cisplatin Injection
1.2.4 Cyclophosphamide Injection
1.2.5 Vincristine Injection
1.2.6 Others
1.3 Anti-tumor Injection Segment by Application
1.3.1 Global Anti-tumor Injection Market Value by Application: (2024-2030)
1.3.2 Breast Cancer
1.3.3 Stomach Cancer
1.3.4 Ovarian Cancer
1.3.5 Lung Cancer
1.3.6 Cervical Cancer
1.3.7 Endometrial Cancer
1.3.8 Prostate Cancer
1.3.9 Bladder Cancer
1.3.10 Others
1.4 Global Anti-tumor Injection Market Size Estimates and Forecasts
1.4.1 Global Anti-tumor Injection Revenue 2019-2030
1.4.2 Global Anti-tumor Injection Sales 2019-2030
1.4.3 Global Anti-tumor Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti-tumor Injection Market Competition by Manufacturers
2.1 Global Anti-tumor Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti-tumor Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti-tumor Injection Average Price by Manufacturers (2019-2024)
2.4 Global Anti-tumor Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-tumor Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-tumor Injection, Product Type & Application
2.7 Anti-tumor Injection Market Competitive Situation and Trends
2.7.1 Anti-tumor Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-tumor Injection Players Market Share by Revenue
2.7.3 Global Anti-tumor Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-tumor Injection Retrospective Market Scenario by Region
3.1 Global Anti-tumor Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti-tumor Injection Global Anti-tumor Injection Sales by Region: 2019-2030
3.2.1 Global Anti-tumor Injection Sales by Region: 2019-2024
3.2.2 Global Anti-tumor Injection Sales by Region: 2025-2030
3.3 Global Anti-tumor Injection Global Anti-tumor Injection Revenue by Region: 2019-2030
3.3.1 Global Anti-tumor Injection Revenue by Region: 2019-2024
3.3.2 Global Anti-tumor Injection Revenue by Region: 2025-2030
3.4 North America Anti-tumor Injection Market Facts & Figures by Country
3.4.1 North America Anti-tumor Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti-tumor Injection Sales by Country (2019-2030)
3.4.3 North America Anti-tumor Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-tumor Injection Market Facts & Figures by Country
3.5.1 Europe Anti-tumor Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti-tumor Injection Sales by Country (2019-2030)
3.5.3 Europe Anti-tumor Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Anti-tumor Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-tumor Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti-tumor Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Anti-tumor Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Anti-tumor Injection Market Facts & Figures by Country
3.7.1 Latin America Anti-tumor Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti-tumor Injection Sales by Country (2019-2030)
3.7.3 Latin America Anti-tumor Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-tumor Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-tumor Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti-tumor Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti-tumor Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-tumor Injection Sales by Type (2019-2030)
4.1.1 Global Anti-tumor Injection Sales by Type (2019-2024)
4.1.2 Global Anti-tumor Injection Sales by Type (2025-2030)
4.1.3 Global Anti-tumor Injection Sales Market Share by Type (2019-2030)
4.2 Global Anti-tumor Injection Revenue by Type (2019-2030)
4.2.1 Global Anti-tumor Injection Revenue by Type (2019-2024)
4.2.2 Global Anti-tumor Injection Revenue by Type (2025-2030)
4.2.3 Global Anti-tumor Injection Revenue Market Share by Type (2019-2030)
4.3 Global Anti-tumor Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti-tumor Injection Sales by Application (2019-2030)
5.1.1 Global Anti-tumor Injection Sales by Application (2019-2024)
5.1.2 Global Anti-tumor Injection Sales by Application (2025-2030)
5.1.3 Global Anti-tumor Injection Sales Market Share by Application (2019-2030)
5.2 Global Anti-tumor Injection Revenue by Application (2019-2030)
5.2.1 Global Anti-tumor Injection Revenue by Application (2019-2024)
5.2.2 Global Anti-tumor Injection Revenue by Application (2025-2030)
5.2.3 Global Anti-tumor Injection Revenue Market Share by Application (2019-2030)
5.3 Global Anti-tumor Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche(Genentech)
6.1.1 Roche(Genentech) Corporation Information
6.1.2 Roche(Genentech) Description and Business Overview
6.1.3 Roche(Genentech) Anti-tumor Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche(Genentech) Anti-tumor Injection Product Portfolio
6.1.5 Roche(Genentech) Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Anti-tumor Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Anti-tumor Injection Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Anti-tumor Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Anti-tumor Injection Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Anti-tumor Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Anti-tumor Injection Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Amgen
6.5.1 Amgen Corporation Information
6.5.2 Amgen Description and Business Overview
6.5.3 Amgen Anti-tumor Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Amgen Anti-tumor Injection Product Portfolio
6.5.5 Amgen Recent Developments/Updates
6.6 Mabxience
6.6.1 Mabxience Corporation Information
6.6.2 Mabxience Description and Business Overview
6.6.3 Mabxience Anti-tumor Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mabxience Anti-tumor Injection Product Portfolio
6.6.5 Mabxience Recent Developments/Updates
6.7 Luoxin Pharmaceutical
6.6.1 Luoxin Pharmaceutical Corporation Information
6.6.2 Luoxin Pharmaceutical Description and Business Overview
6.6.3 Luoxin Pharmaceutical Anti-tumor Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Luoxin Pharmaceutical Anti-tumor Injection Product Portfolio
6.7.5 Luoxin Pharmaceutical Recent Developments/Updates
6.8 Qilu Pharmaceutical
6.8.1 Qilu Pharmaceutical Corporation Information
6.8.2 Qilu Pharmaceutical Description and Business Overview
6.8.3 Qilu Pharmaceutical Anti-tumor Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Qilu Pharmaceutical Anti-tumor Injection Product Portfolio
6.8.5 Qilu Pharmaceutical Recent Developments/Updates
6.9 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.)
6.9.1 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Corporation Information
6.9.2 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Description and Business Overview
6.9.3 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Anti-tumor Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Anti-tumor Injection Product Portfolio
6.9.5 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Recent Developments/Updates
6.10 Fuxing Medicine
6.10.1 Fuxing Medicine Corporation Information
6.10.2 Fuxing Medicine Description and Business Overview
6.10.3 Fuxing Medicine Anti-tumor Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Fuxing Medicine Anti-tumor Injection Product Portfolio
6.10.5 Fuxing Medicine Recent Developments/Updates
6.11 Yuekang Pharmaceutical
6.11.1 Yuekang Pharmaceutical Corporation Information
6.11.2 Yuekang Pharmaceutical Anti-tumor Injection Description and Business Overview
6.11.3 Yuekang Pharmaceutical Anti-tumor Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Yuekang Pharmaceutical Anti-tumor Injection Product Portfolio
6.11.5 Yuekang Pharmaceutical Recent Developments/Updates
6.12 Yuheng Pharmaceutical
6.12.1 Yuheng Pharmaceutical Corporation Information
6.12.2 Yuheng Pharmaceutical Anti-tumor Injection Description and Business Overview
6.12.3 Yuheng Pharmaceutical Anti-tumor Injection Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Yuheng Pharmaceutical Anti-tumor Injection Product Portfolio
6.12.5 Yuheng Pharmaceutical Recent Developments/Updates
6.13 Hengrui Medicine
6.13.1 Hengrui Medicine Corporation Information
6.13.2 Hengrui Medicine Anti-tumor Injection Description and Business Overview
6.13.3 Hengrui Medicine Anti-tumor Injection Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hengrui Medicine Anti-tumor Injection Product Portfolio
6.13.5 Hengrui Medicine Recent Developments/Updates
6.14 Huiyu Pharmaceutical
6.14.1 Huiyu Pharmaceutical Corporation Information
6.14.2 Huiyu Pharmaceutical Anti-tumor Injection Description and Business Overview
6.14.3 Huiyu Pharmaceutical Anti-tumor Injection Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Huiyu Pharmaceutical Anti-tumor Injection Product Portfolio
6.14.5 Huiyu Pharmaceutical Recent Developments/Updates
6.15 Changbaishan Pharmaceutical Co., Ltd.
6.15.1 Changbaishan Pharmaceutical Co., Ltd. Corporation Information
6.15.2 Changbaishan Pharmaceutical Co., Ltd. Anti-tumor Injection Description and Business Overview
6.15.3 Changbaishan Pharmaceutical Co., Ltd. Anti-tumor Injection Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Changbaishan Pharmaceutical Co., Ltd. Anti-tumor Injection Product Portfolio
6.15.5 Changbaishan Pharmaceutical Co., Ltd. Recent Developments/Updates
6.16 Innovent Biologics (Suzhou) Co., Ltd.
6.16.1 Innovent Biologics (Suzhou) Co., Ltd. Corporation Information
6.16.2 Innovent Biologics (Suzhou) Co., Ltd. Anti-tumor Injection Description and Business Overview
6.16.3 Innovent Biologics (Suzhou) Co., Ltd. Anti-tumor Injection Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Innovent Biologics (Suzhou) Co., Ltd. Anti-tumor Injection Product Portfolio
6.16.5 Innovent Biologics (Suzhou) Co., Ltd. Recent Developments/Updates
6.17 Yifan Pharmaceutical
6.17.1 Yifan Pharmaceutical Corporation Information
6.17.2 Yifan Pharmaceutical Anti-tumor Injection Description and Business Overview
6.17.3 Yifan Pharmaceutical Anti-tumor Injection Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Yifan Pharmaceutical Anti-tumor Injection Product Portfolio
6.17.5 Yifan Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-tumor Injection Industry Chain Analysis
7.2 Anti-tumor Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-tumor Injection Production Mode & Process
7.4 Anti-tumor Injection Sales and Marketing
7.4.1 Anti-tumor Injection Sales Channels
7.4.2 Anti-tumor Injection Distributors
7.5 Anti-tumor Injection Customers
8 Anti-tumor Injection Market Dynamics
8.1 Anti-tumor Injection Industry Trends
8.2 Anti-tumor Injection Market Drivers
8.3 Anti-tumor Injection Market Challenges
8.4 Anti-tumor Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Anti-tumor Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Anti-tumor Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Anti-tumor Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Anti-tumor Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Anti-tumor Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Anti-tumor Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Anti-tumor Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Anti-tumor Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Anti-tumor Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-tumor Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-tumor Injection, Product Type & Application
Table 12. Global Key Manufacturers of Anti-tumor Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-tumor Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-tumor Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-tumor Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Anti-tumor Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Anti-tumor Injection Sales Market Share by Region (2019-2024)
Table 19. Global Anti-tumor Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Anti-tumor Injection Sales Market Share by Region (2025-2030)
Table 21. Global Anti-tumor Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Anti-tumor Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Anti-tumor Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Anti-tumor Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Anti-tumor Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Anti-tumor Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Anti-tumor Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Anti-tumor Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Anti-tumor Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Anti-tumor Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Anti-tumor Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Anti-tumor Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Anti-tumor Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Anti-tumor Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Anti-tumor Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Anti-tumor Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Anti-tumor Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Anti-tumor Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Anti-tumor Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anti-tumor Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Anti-tumor Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Anti-tumor Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Anti-tumor Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Anti-tumor Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Anti-tumor Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Anti-tumor Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Anti-tumor Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Anti-tumor Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Anti-tumor Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Anti-tumor Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Anti-tumor Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Anti-tumor Injection Sales Market Share by Type (2019-2024)
Table 53. Global Anti-tumor Injection Sales Market Share by Type (2025-2030)
Table 54. Global Anti-tumor Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Anti-tumor Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Anti-tumor Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Anti-tumor Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Anti-tumor Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Anti-tumor Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Anti-tumor Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Anti-tumor Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Anti-tumor Injection Sales Market Share by Application (2019-2024)
Table 63. Global Anti-tumor Injection Sales Market Share by Application (2025-2030)
Table 64. Global Anti-tumor Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Anti-tumor Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Anti-tumor Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Anti-tumor Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Anti-tumor Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Anti-tumor Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Roche(Genentech) Corporation Information
Table 71. Roche(Genentech) Description and Business Overview
Table 72. Roche(Genentech) Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Roche(Genentech) Anti-tumor Injection Product
Table 74. Roche(Genentech) Recent Developments/Updates
Table 75. Bayer Corporation Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Bayer Anti-tumor Injection Product
Table 79. Bayer Recent Developments/Updates
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Novartis Anti-tumor Injection Product
Table 84. Novartis Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Pfizer Anti-tumor Injection Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Amgen Corporation Information
Table 91. Amgen Description and Business Overview
Table 92. Amgen Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Amgen Anti-tumor Injection Product
Table 94. Amgen Recent Developments/Updates
Table 95. Mabxience Corporation Information
Table 96. Mabxience Description and Business Overview
Table 97. Mabxience Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Mabxience Anti-tumor Injection Product
Table 99. Mabxience Recent Developments/Updates
Table 100. Luoxin Pharmaceutical Corporation Information
Table 101. Luoxin Pharmaceutical Description and Business Overview
Table 102. Luoxin Pharmaceutical Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Luoxin Pharmaceutical Anti-tumor Injection Product
Table 104. Luoxin Pharmaceutical Recent Developments/Updates
Table 105. Qilu Pharmaceutical Corporation Information
Table 106. Qilu Pharmaceutical Description and Business Overview
Table 107. Qilu Pharmaceutical Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Qilu Pharmaceutical Anti-tumor Injection Product
Table 109. Qilu Pharmaceutical Recent Developments/Updates
Table 110. Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Corporation Information
Table 111. Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Description and Business Overview
Table 112. Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Anti-tumor Injection Product
Table 114. Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Recent Developments/Updates
Table 115. Fuxing Medicine Corporation Information
Table 116. Fuxing Medicine Description and Business Overview
Table 117. Fuxing Medicine Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Fuxing Medicine Anti-tumor Injection Product
Table 119. Fuxing Medicine Recent Developments/Updates
Table 120. Yuekang Pharmaceutical Corporation Information
Table 121. Yuekang Pharmaceutical Description and Business Overview
Table 122. Yuekang Pharmaceutical Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Yuekang Pharmaceutical Anti-tumor Injection Product
Table 124. Yuekang Pharmaceutical Recent Developments/Updates
Table 125. Yuheng Pharmaceutical Corporation Information
Table 126. Yuheng Pharmaceutical Description and Business Overview
Table 127. Yuheng Pharmaceutical Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Yuheng Pharmaceutical Anti-tumor Injection Product
Table 129. Yuheng Pharmaceutical Recent Developments/Updates
Table 130. Hengrui Medicine Corporation Information
Table 131. Hengrui Medicine Description and Business Overview
Table 132. Hengrui Medicine Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Hengrui Medicine Anti-tumor Injection Product
Table 134. Hengrui Medicine Recent Developments/Updates
Table 135. Huiyu Pharmaceutical Corporation Information
Table 136. Huiyu Pharmaceutical Description and Business Overview
Table 137. Huiyu Pharmaceutical Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Huiyu Pharmaceutical Anti-tumor Injection Product
Table 139. Huiyu Pharmaceutical Recent Developments/Updates
Table 140. Changbaishan Pharmaceutical Co., Ltd. Corporation Information
Table 141. Changbaishan Pharmaceutical Co., Ltd. Description and Business Overview
Table 142. Changbaishan Pharmaceutical Co., Ltd. Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Changbaishan Pharmaceutical Co., Ltd. Anti-tumor Injection Product
Table 144. Changbaishan Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 145. Innovent Biologics (Suzhou) Co., Ltd. Corporation Information
Table 146. Innovent Biologics (Suzhou) Co., Ltd. Description and Business Overview
Table 147. Innovent Biologics (Suzhou) Co., Ltd. Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Innovent Biologics (Suzhou) Co., Ltd. Anti-tumor Injection Product
Table 149. Innovent Biologics (Suzhou) Co., Ltd. Recent Developments/Updates
Table 150. Yifan Pharmaceutical Corporation Information
Table 151. Yifan Pharmaceutical Description and Business Overview
Table 152. Yifan Pharmaceutical Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Yifan Pharmaceutical Anti-tumor Injection Product
Table 154. Yifan Pharmaceutical Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Anti-tumor Injection Distributors List
Table 158. Anti-tumor Injection Customers List
Table 159. Anti-tumor Injection Market Trends
Table 160. Anti-tumor Injection Market Drivers
Table 161. Anti-tumor Injection Market Challenges
Table 162. Anti-tumor Injection Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-tumor Injection
Figure 2. Global Anti-tumor Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Anti-tumor Injection Market Share by Type in 2023 & 2030
Figure 4. Paclitaxel Injection Product Picture
Figure 5. Cisplatin Injection Product Picture
Figure 6. Cyclophosphamide Injection Product Picture
Figure 7. Vincristine Injection Product Picture
Figure 8. Others Product Picture
Figure 9. Global Anti-tumor Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Anti-tumor Injection Market Share by Application in 2023 & 2030
Figure 11. Breast Cancer
Figure 12. Stomach Cancer
Figure 13. Ovarian Cancer
Figure 14. Lung Cancer
Figure 15. Cervical Cancer
Figure 16. Endometrial Cancer
Figure 17. Prostate Cancer
Figure 18. Bladder Cancer
Figure 19. Others
Figure 20. Global Anti-tumor Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 21. Global Anti-tumor Injection Market Size (2019-2030) & (US$ Million)
Figure 22. Global Anti-tumor Injection Sales (2019-2030) & (K Units)
Figure 23. Global Anti-tumor Injection Average Price (US$/Unit) & (2019-2030)
Figure 24. Anti-tumor Injection Report Years Considered
Figure 25. Anti-tumor Injection Sales Share by Manufacturers in 2023
Figure 26. Global Anti-tumor Injection Revenue Share by Manufacturers in 2023
Figure 27. The Global 5 and 10 Largest Anti-tumor Injection Players: Market Share by Revenue in 2023
Figure 28. Anti-tumor Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 29. Global Anti-tumor Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 30. North America Anti-tumor Injection Sales Market Share by Country (2019-2030)
Figure 31. North America Anti-tumor Injection Revenue Market Share by Country (2019-2030)
Figure 32. United States Anti-tumor Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Canada Anti-tumor Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Europe Anti-tumor Injection Sales Market Share by Country (2019-2030)
Figure 35. Europe Anti-tumor Injection Revenue Market Share by Country (2019-2030)
Figure 36. Germany Anti-tumor Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. France Anti-tumor Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. U.K. Anti-tumor Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Italy Anti-tumor Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Netherlands Anti-tumor Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Asia Pacific Anti-tumor Injection Sales Market Share by Region (2019-2030)
Figure 42. Asia Pacific Anti-tumor Injection Revenue Market Share by Region (2019-2030)
Figure 43. China Anti-tumor Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Japan Anti-tumor Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. South Korea Anti-tumor Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. India Anti-tumor Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Anti-tumor Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. China Taiwan Anti-tumor Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Australia Anti-tumor Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Latin America Anti-tumor Injection Sales Market Share by Country (2019-2030)
Figure 51. Latin America Anti-tumor Injection Revenue Market Share by Country (2019-2030)
Figure 52. Mexico Anti-tumor Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Brazil Anti-tumor Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Argentina Anti-tumor Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Colombia Anti-tumor Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Middle East & Africa Anti-tumor Injection Sales Market Share by Country (2019-2030)
Figure 57. Middle East & Africa Anti-tumor Injection Revenue Market Share by Country (2019-2030)
Figure 58. Turkey Anti-tumor Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. Saudi Arabia Anti-tumor Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 60. UAE Anti-tumor Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 61. Global Sales Market Share of Anti-tumor Injection by Type (2019-2030)
Figure 62. Global Revenue Market Share of Anti-tumor Injection by Type (2019-2030)
Figure 63. Global Anti-tumor Injection Price (US$/Unit) by Type (2019-2030)
Figure 64. Global Sales Market Share of Anti-tumor Injection by Application (2019-2030)
Figure 65. Global Revenue Market Share of Anti-tumor Injection by Application (2019-2030)
Figure 66. Global Anti-tumor Injection Price (US$/Unit) by Application (2019-2030)
Figure 67. Anti-tumor Injection Value Chain
Figure 68. Anti-tumor Injection Production Process
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Distributors Profiles
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
